US Patent Issued to REMEGEN on Jan. 20 for "Anti-c-Met antibody-drug conjugate and applications thereof" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,870, issued on Jan. 20, was assigned to REMEGEN Co. LTD. (Yantai, China).

"Anti-c-Met antibody-drug conjugate and applications thereof" was invented by Jianmin Fang (Yantai, China), Changjiang Huang (Yantai, China), Xuejing Yao (Yantai, China) and Wenting Luo (Yantai, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the technical field of c-Met antibody drugs, specifically to a c-Met-targeted antibody-drug conjugate and applications thereof. The antibody-drug conjugate of the present disclosure comprises an antibody conjugated with one or more therapeutic agents or antigen-binding fragments of the antibody, is a...